D
Danaher
Global science and technology innovator
About Danaher
Danaher Corporation is a global science and technology innovator that operates in several key markets, including water quality, product identification, and diagnostics. The company serves a diverse range of clients, from municipal and wastewater treatment facilities to industrial and manufacturing environments, as well as consumer, industrial, and pharmaceutical sectors. Additionally, Danaher provides advanced diagnostic tools and software to healthcare providers worldwide.
In the water quality sector, Danaher offers precision instruments and advanced purification technologies that help analyze, treat, and manage water in various settings, including municipal and industrial applications. Their products ensure the safety and quality of water in lakes, streams, and oceans.
In the product identification market, Danaher’s businesses are leaders in laser marking, coding, engraving, integrated packaging solutions, and color science. These technologies are crucial for maintaining the freshness, consistency, and accurate labeling and tracking of products throughout the supply chain.
In the diagnostics field, Danaher provides cutting-edge tools and software that enhance diagnostic confidence and safeguard patient health. Their automated processes and point-of-care solutions enable medical practitioners to deliver effective preventative and predictive care.
Danaher’s business model revolves around the Danaher Business System, a unique approach that empowers its employees to lead change and drive continuous improvement. This system has been a significant factor in the company’s long-term success and superior financial performance, as evidenced by its total shareholder return exceeding the S&P 500 Equity Index by over 5,000% from June 15, 1994, to June 15, 2019.
The company generates revenue through the sale of its high-performance products and solutions across its various business segments. By consistently delivering superior results and rising to industry challenges, Danaher has established itself as a leader in its served markets.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1969
- Headquarters
- Washington DC, United States
- Listing
- IPO 1979
- Employees
- 60,544
- Open positions
- 167
- Dealroom signal
- 91.6/100
- Industry
- Health
- Sector
- Health, Health Diagnostics
- Client focus
- b2b
- Investment activity
- 47 companies, latest Feb 2026
- Capital deployed
- $228M
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Apr 2026 | $3B | — | Undisclosed | ↗ |
| POST IPO DEBT✓Debt | Apr 2026 | $5B | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Danaher is 390K monthly website visits, up 62.5% over the last three months. Danaher's team grew 21.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Neurovascular DiagnosticsNeurovascular Diagnostics is developing a low-cost, blood diagnostic to detect unruptured brain aneurysms |
Buffalo, United States | Operational | 3 | $5M | — |
DiamiRA leading molecular diagnostics company |
South Brunswick, United States | Operational | |||
MolsidWe fight AMR with Faster Diagnostics |
Lyon, France | Operational | |||
Lucira HealthIVD, Consumer Health, Disposable Testing |
Emeryville, United States | Acquired | |||
Probably GeneticProbably Genetic helps rare genetic disease patients get diagnosed |
San Francisco, United States | Operational | |||
GeneCast / 臻和Wuxi oncology multi-omics / NGS diagnostics OEM |
Wuxi, China | Operational | |||
GrandOmicsGrandomics provides molecular diagnosis, research, and carrier screening for single gene diseases |
Dongcheng District, China | Operational | |||
| Qingdao, China | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
MasimoNeuchâtel, SwitzerlandMedical technology company that develops, manufactures, and markets noninvasive patient monitoring products
$9.7Bvaluation
GenedataBasel, SwitzerlandEnterprise Solutions for More Efficient R&D: Genedata AG
→
AbcamCambridge, United KingdomLife science protein research tools and reagents
$5.7Bvaluation
ARCS FoundationLaGrange, United States
→
DNA ScriptLe Kremlin-Bicêtre, FranceTransforming how molecular biology translates to human health, personalized medicine, and synthetic biology
$825Mvaluation
Precision NanoSystemVancouver, CanadaNeuro9kit for the study of gene function in neurons and glia cells
$24Mvaluation
AldevronFargo, United StatesContract development and manufacturing organization specializing in the production of plasmid dna
$9.6Bvaluation
Aquatic InformaticsVancouver, CanadaWater Data Management Software
→
CytivaMarlborough, United StatesSpecializes in advancing research and biopharmaceutical manufacturing through innovative technologies, tools, and expertise
$21Bvaluation
EnvistaBrea, United StatesComprehensive portfolio of dental products and technology solutions
$4.3Bvaluation
Integrated DNA TechnologiesCoralville, United StatesIntegrated DNA Technologies sells short strands of DNA called oligonucleotides
→
AVTHod Hasharon, IsraelPrint and Press Process Control for Packaging and Commercial Printing
$100Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Bornite Capital Management
Oribel Capital Management
Other known investors1 additional known investor
Rob Soni
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Danaher on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Danaher’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






